0001384101-23-000132.txt : 20230719 0001384101-23-000132.hdr.sgml : 20230719 20230719203544 ACCESSION NUMBER: 0001384101-23-000132 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230717 FILED AS OF DATE: 20230719 DATE AS OF CHANGE: 20230719 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BISHOP JOHN L CENTRAL INDEX KEY: 0001189846 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36156 FILM NUMBER: 231097924 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERACYTE, INC. CENTRAL INDEX KEY: 0001384101 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 205455398 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6000 SHORELINE COURT, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 243-6300 MAIL ADDRESS: STREET 1: 6000 SHORELINE COURT, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: CALDEROME INC DATE OF NAME CHANGE: 20061219 4 1 wk-form4_1689813334.xml FORM 4 X0508 4 2023-07-17 0 0001384101 VERACYTE, INC. VCYT 0001189846 BISHOP JOHN L 6000 SHORELINE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080 1 0 0 0 1 Common Stock 2023-07-17 4 M 0 10000 6.37 A 43125 D Common Stock 2023-07-17 4 S 0 10000 30.0002 D 33125 D Common Stock 2023-07-18 4 M 0 10000 6.37 A 43125 D Common Stock 2023-07-18 4 S 0 10000 30.50 D 33125 D Stock Option (right to buy) 6.37 2023-07-17 4 M 0 10000 0 D 2024-12-01 Common Stock 10000 25000 D Stock Option (right to buy) 6.37 2023-07-18 4 M 0 10000 0 D 2024-12-01 Common Stock 10000 15000 D The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 28, 2023. Represents weighted average sales price. Sale prices for the transactions range from $30.00 to $30.03. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. The option is fully vested. /s/ Jonathan Wygant, as attorney-in-fact 2023-07-19